Menu
Recruiting NCT05689944

Dance-therapy and Chronic Pain

No phase Interventional Chronic Pain Complex Regional Pain Syndromes Tension-Type Headache

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Dance-therapy, Art-therapy, Yoga.
Who it may be relevant to
Registry conditions: Chronic Pain, Complex Regional Pain Syndromes, Tension-Type Headache. Basic parameters: 12 years — 20 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of Dance-therapy on Chronic Adolescent Pain Patients - a Randomized Controlled Trial Study

Overview

Pain, when it becomes chronic, can be a threat to patients and it is very common to observe a fear of pain and a fear of movement (kinesiophobia). Avoidance of movement due to fear of pain can lead to a deterioration of body image. Non-medicinal therapies are essential to correct this fear and movement avoidance behavior, to decrease "catastrophic" judgments and thus anxiety. The use of art-therapy in the accompaniment of patients with pain has shown, in particular, decreases in the intensity of pain, the level of anxiety, an improvement in stress, mood and overall psychological state. However, according to the current literature, it appears that 1) this technique is rarely used in children or adolescents, for whom non-medicinal therapies are fundamental, and 2) in the case of chronic pain, the form of art used is very rarely related to the body (most often painting, drawing, music...). In this project, investigators propose to set up and test the potential benefit of art-therapy sessions related to the body, namely dance-therapy, in adolescents and young adults suffering from chronic pain.

Interventions

  • Behavioral Dance-therapy
    This session will take place once a week between weeks 1 and 15 of the protocol. * 5 mn of welcome and presentation of the upcoming session * 5 mn of self-evaluation of the pain as well as of the thymia and the fatigue before the beginning of the session (Visual numerical scales: VNS) * 15 mn of body warm-up with taught contemporary dance exercises * 15 mn of creative research based on dance improvisation on a given theme * 15 mn of sharing for the elaboration of a choreography * At the end of
  • Behavioral Art-therapy
    This session will take place once a week between weeks 1 and 15 of the protocol. * 5 mn of welcome and presentation of the upcoming session * 5 mn of self-evaluation of the pain as well as of the thymia and the fatigue before the beginning of the session (Visual numerical scales: VNS) * 10 mn of discovery of a new technique (acrylic painting or collage). * 35 mn of practice in a project fixed beforehand * At the end of the session, 5mn of self-evaluation of the pain, the thymia, the fatigue and
  • Behavioral Yoga
    This session will take place once a week between weeks 1 and 15 of the protocol. * 5 mn welcome * 5 mn of self-evaluation of the pain as well as of the thymia and the fatigue before the beginning of the session (Visual numerical scales: VNS) * 50 mn of Vinyasa type yoga (warm-up, breathing, balance, strength and flexibility, relaxation) * 5 mn of closing of the session * At the end of the session, 5mn of self-evaluation of the pain thanks, the thymia, the fatigue and the level of appreciation o

Primary outcome measures

  • Assesment of pain change [Time frame: Weeks 0, 5, 16, 20 and 28.]
Secondary outcome measures (10)
  • Kinesiophobia [Time frame: Inclusion, weeks 5, 16, 20, 28.]
  • Anxiety (adolescents) [Time frame: Inclusion, weeks 5, 16, 20, 28]
  • Anxiety (adults) [Time frame: Inclusion, weeks 5, 16, 20, 28]
  • Pain catastrophizing [Time frame: Inclusion, weeks 5, 16, 20, 28.]
  • Fear of Pain (adolescents) [Time frame: Inclusion, weeks 5, 16, 20, 28.]
  • Fear of Pain (adults) [Time frame: Inclusion, weeks 5, 16, 20, 28.]
  • Incidence of art therapy on quality of life (adolescents) [Time frame: Inclusion, weeks 5, 16, 20, 28.]
  • Incidence of art therapy on quality of life (adults) [Time frame: Inclusion, weeks 5, 16, 20, 28.]
  • Body satisfaction and global self-perception [Time frame: Inclusion, weeks 5, 16, 20, 28.]
  • Incidence of art therapy on sleep quality [Time frame: Weeks 0, 5, 16, 20 and 28.]

Eligibility criteria

Inclusion criteria

  • Patients aged 12 to 20 years, girls or boys, with chronic pain.
  • Diagnosis of chronic pain made in a Pain Management Center
  • Patients followed in a Pain Management Center (to ensure that patients entering the protocol have pain that is not relieved by conventional treatments)
  • Patients who have given written consent for adults or whose parents have given consent for minors
  • Patients who are affiliated with or benefit from a social security system.

Exclusion criteria

  • Patients with other neurological or psychological disorders
  • Patients with psychiatric illnesses
  • Patients with chronic infectious, metabolic, cancerous, autoimmune diseases.
  • Non-communicating patients including deaf and hard of hearing patients
  • Patients or parents who do not speak or read French
  • Pregnant women
  • Dance or yoga professionals (dance or yoga teachers or those studying to become teachers)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Other

Study locations

France · 1 center
  • Neuroscience Research Center of Lyon (CRNL)- INSERM U1028 - NEUROPAIN laboratory — Bron

Identifiers

NCT: NCT05689944 · 69HCL22_0361

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗